Body Bazaar: The Market for Human Tissue in the Biotechnology Age
Can a human being be reduced to the sum of his or her body's parts? In a curious turnaround, science and industry are making the case that our selves are separate from and even the owners of our flesh and bone, rather than the meat machines 20th-century biologists posited. That this reversal is to their advantage and profit is the theme ofBody Bazaar: The Market for Human Tissue in the Biotechnology Age.Authors Lori B. Andrews and Dorothy Nelkin, each intimately involved in the struggle to define the laws and issues of the biotech age, make a strong and clear case against the newfound rights of business interests to harvest our bodies and derive exclusive profit from the resulting products and processes. Though some of their arguments are unconvincing--while it is certainly true that many cultures hold blood and other tissues sacred or at least taboo, such beliefs would seem to pale before, say, a cure for cancer--on the whole, the reader is left with a sense of urgency that harm is being done to an unsuspecting population of health care consumers unknowingly mined for new biological properties and to humanity itself, rightly expecting the same selflessness from the medical community that eradicated smallpox and smashed polio with little to no profit for the principals. Using stories of individuals injured or abused by the increasingly rapacious biotech industry and their own careful analysis of the changing intellectual property laws governing the mess, the authors warn of a dehumanized world unimaginable even a few decades ago. Whether we'll avoid the pitfalls of our new tech or simply cope with the results is a question for history.--Rob Lightner